Searched for
TIRUPATI MEDICARE
Pharma & healthcare deals see shifting focus on scalable, global models: Grant Thornton BharatIndia's pharma and healthcare sector demonstrates resilient investor interest, marked by a 34% year-on-year increase in deal volumes and a ...- Kotak arm invests Rs 1,050 cr in Tirupati MedicareKotak Alternate Asset Managers has invested Rs 1,050 crore in Tirupati Medicare to support its expansion and provide a complete exit for Af...
- Kotak arm invests Rs 1,050 cr in Tirupati MedicareKotak Alternate Asset Managers announced a Rs 1,050-crore investment in Tirupati Medicare to aid its expansion, enabling a full exit for Af...
- Stock market update: Nifty Pharma index advances 0.33%The Nifty Pharma index closed 0.33 per cent up at 23005.25.
- Stock market update: Nifty IT index advances 0.62%The Nifty IT index closed 0.62 per cent up at 42204.4.
- Stock market update: Nifty Bank index advances 1.42%The Nifty Bank index closed 1.42 per cent up at 53793.2.
- Stock market update: Stocks that hit 52-week lows on NSE in today's tradeGrasim Inds., SBI, IndusInd Bank, TCS and Bajaj Finance were among the top losers on NSE in today's trade.
- Stock market update: Stocks that hit 52-week highs on NSE in today's tradeSobha (PP), Marksans Pharma, Concord Biotech Ltd., Interarch Building and Themis Medicare, hit their fresh 52-week highs during the day.
- Stock market update: Nifty Realty index advances 3.05%The Nifty Realty index closed 3.05 per cent up at 1101.6.
- Stock market update: Stocks that hit 52-week lows on NSETech Mahindra, Wipro, Infosys, LTIMindtree and TCS were among the top losers on NSE.
- NCLT approves Innova Captab's resolution plan for Sharon BioThe Mumbai bench of the National Company Law Tribunal (NCLT) has approved ₹256.4 crore resolution plan of Innova Captab for Sharon Bio Medi...
- Piramal, Cadila among 32 companies in race to buy Sharon Bio-MedicineSome fund houses, including iLabs India Special Situations Fund, Edelweiss Alternative Assets Advisors, Capri Global Holdings, ACRE India, ...
- Affirma Capital buys stake in Prodapt for $70 millionProdapt is the Affirma Capital team’s fourth investment in India in the past 12 months.
- Market Now: These stocks cracked over 10% todayIn the Nifty50 pack, 14 stocks were trading in green, while 37 stocks were in red.
- PE funds like Motilal Oswal, Baring and IDFC tap small town venturesCompanies based in tier-II and III towns and cities are clocking a steady rate of growth, attracting investor interest towards these non-me...
Load More
